Rapid inter-procedural 3D scanning of fine-needle aspiration cytology slides with a parallelized microscope - significance: fine needle aspiration (FNA) biopsies are a critical first step in the…
Active Grant Awarded Last action
- Award ID
- R43CA310398
- Recipient
-
Ramona Optics Inc. UEI MR4ZCJJQHHP5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $306,872
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date 69% complete
- Originally
- Place of performance
- Durham, NC 27701, USA
Award details come from USAspending.gov.
Description
Rapid inter-procedural 3D scanning of fine-needle aspiration cytology slides with a parallelized microscope - significance: fine needle aspiration (FNA) biopsies are a critical first step in the cancer diagnosis pipeline, wherein specimen material is extracted from a suspected pathological lesion and smeared onto a microscope slide. Cytopathologists then examine three-dimensional groups of cells across the entire slide for diagnostic purposes. Ideally, a cytopathologist is available in-person to perform "rapid on-site evaluation" (ROSE) during such FNA biopsy procedures, like bronchoscopies, which is known to increase positive predictive value and decreases procedure time for cancer diagnosis. Unfortunately, relatively few cytotechnologists and pathologists are available to perform ROSE, most notably outside of large hospital settings. Without ROSE, proceduralists generally do not know if they have obtained adequate specimen material for diagnostic review, or how to triage such samples, which leads to additional patient visits, additional procedures, and increased risk of side effect and harm. Proposal: in this project, ramona optics and the duke medical center aim to develop a new imaging system, termed a multi-camera array scanner (MCAS), that rapidly digitizes and automatically analyzes thick FNA cytology smears in 3D. The MCAS will provide real-time (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $306,872 |
Quick answers
Who received award R43CA310398?
R43CA310398 was awarded to Ramona Optics Inc. by National Cancer Institute (National Institutes of Health) on September 9, 2025.
How much is award R43CA310398 worth?
$306,872 has been obligated on R43CA310398.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award